Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Interleukin-2 × Clear all

Phase

Status

Active not recruiting 3 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Breast Neoplasms 6 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid 2 Leukemia 2 Glioblastoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Select Advanced Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Follicular 1

Interventions

pembrolizumab 45 Carboplatin 38 Pemetrexed 34 Magnetic Resonance Spectroscopy 33 Specimen Handling 32 Cisplatin 25 Blood Specimen Collection 20 Paclitaxel 15 Radiosurgery 14 durvalumab 13 Radiotherapy 13 Gemcitabine 12 Bevacizumab 12 osimertinib 11 atezolizumab 11 Biopsy 11 Practice Guidelines as Topic 10 Nivolumab 10 Educational Status 9 130-nm albumin-bound paclitaxel 9 X-Rays 8 Standard of Care 8 Immunoglobulin G 8 Docetaxel 8 Surveys and Questionnaires 7 Disulfides 7 Cetuximab 7 Taxes 6 Etoposide 6 Drug Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06538012 2024-10-15

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡